291 related articles for article (PubMed ID: 22451420)
1. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
2. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
4. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract][Full Text] [Related]
5. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
[TBL] [Abstract][Full Text] [Related]
6. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
Barberi T; Cui C; Friedman AD
PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
[TBL] [Abstract][Full Text] [Related]
7. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
8. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
Guo H; Ma O; Friedman AD
J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
[TBL] [Abstract][Full Text] [Related]
9. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
Simeoni F; Romero-Camarero I; Camera F; Amaral FMR; Sinclair OJ; Papachristou EK; Spencer GJ; Lie-A-Ling M; Lacaud G; Wiseman DH; Carroll JS; Somervaille TCP
Cell Rep; 2021 Sep; 36(12):109725. PubMed ID: 34551306
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
[TBL] [Abstract][Full Text] [Related]
11. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
12. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
Tokita K; Maki K; Mitani K
Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
[TBL] [Abstract][Full Text] [Related]
13. Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.
Leong WY; Guo H; Ma O; Huang H; Cantor AB; Friedman AD
J Biol Chem; 2016 Jan; 291(2):826-36. PubMed ID: 26598521
[TBL] [Abstract][Full Text] [Related]
14. SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.
Zhang L; Friedman AD
Blood; 2011 Aug; 118(8):2266-74. PubMed ID: 21725048
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CCAAT/Enhancer Binding Protein (C/EBP) Alpha (CEBPA) and Runt-Related Transcription Factor 1 (RUNX1) Expression in Patients with De Novo Acute Myeloid Leukemia.
Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Farsani MA
Ann Hum Genet; 2017 Nov; 81(6):276-283. PubMed ID: 28895127
[TBL] [Abstract][Full Text] [Related]
16. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
[TBL] [Abstract][Full Text] [Related]
17. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
18. Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.
Fasan A; Alpermann T; Haferlach C; Grossmann V; Roller A; Kohlmann A; Eder C; Kern W; Haferlach T; Schnittger S
PLoS One; 2013; 8(2):e54365. PubMed ID: 23383300
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs.
Gerritsen M; Yi G; Tijchon E; Kuster J; Schuringa JJ; Martens JHA; Vellenga E
Blood Adv; 2019 Feb; 3(3):320-332. PubMed ID: 30709863
[TBL] [Abstract][Full Text] [Related]
20. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
